Genes, proteins, and neurotoxins involved in Parkinson's disease

Progress in Neurobiology
O von Bohlen und HalbachK Krieglstein

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder. The etiology of PD is likely due to combinations of environmental and genetic factors. In addition to the loss of neurons, including dopaminergic neurons in the substantia nigra pars compacta, a further morphologic hallmark of PD is the presence of Lewy bodies and Lewy neurites. The formation of these proteinaceous inclusions involves interaction of several proteins, including alpha-synuclein, synphilin-1, parkin and UCH-L1. Animal models allow to get insight into the mechanisms of several symptoms of PD, allow investigating new therapeutic strategies and, in addition, provide an indispensable tool for basic research. In animals PD does not arise spontaneously, thus, characteristic and specific functional changes have to be mimicked by application of neurotoxic agents or by genetic manipulations. In this review we will focus on genes and gene loci involved in PD, the functions of proteins involved in the formation of cytoplasmatic inclusions, their interactions, and their possible role in PD. In addition, we will review the current animal models of PD.

References

Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·U Ungerstedt
Aug 1, 1992·Biochemical Society Transactions·K D WilkinsonC N Larsen
Oct 1, 1991·Brain Research. Molecular Brain Research·L Maroteaux, R H Scheller
Jan 1, 1991·European Neurology·W R Gibb
Feb 1, 1986·Annals of Neurology·S M Rothman, J W Olney
Feb 23, 1987·Life Sciences·W J NicklasR E Heikkila
Nov 13, 1984·European Journal of Pharmacology·J A Javitch, S H Snyder
Oct 1, 1995·Trends in Pharmacological Sciences·I Mody, J F MacDonald
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·B S JeonR E Burke
Aug 1, 1994·Scandinavian Journal of Work, Environment & Health·G MecoE Fabrizio
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·D T DexterC D Marsden
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K UédaT Saitoh
Jun 1, 1996·Journal of Chemical Neuroanatomy·V L Dawson, T M Dawson
Nov 15, 1996·Science·M H PolymeropoulosR C Duvoisin
Jan 1, 1996·Critical Reviews in Neurobiology·C Ikonomidou, L Turski
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·N TakahashiG R Uhl
Nov 5, 1997·Trends in Pharmacological Sciences·P J RichardsonP G Jenner
Jun 13, 1998·American Journal of Human Genetics·W D Parker, R H Swerdlow
May 23, 1998·The Journal of Biological Chemistry·W S DavidsonJ M George
May 28, 1998·Neuroreport·L HongY H Suh
Aug 26, 1998·Neurology·T N ChaseP J Blanchet

❮ Previous
Next ❯

Citations

Jun 5, 2008·Journal of Neural Transmission·Ilse S PienaarJürgen Götz
Apr 30, 2013·Journal of Molecular Neuroscience : MN·Dwayne BrownYousef Tizabi
Aug 31, 2012·Molecular Neurobiology·Blanca A SilvaVladimir N Uversky
Sep 4, 2012·Molecular Neurobiology·Blanca A SilvaVladimir N Uversky
Apr 5, 2005·Brain Research·Verian BaderChristine C Stichel
Jul 5, 2012·IET Systems Biology·M CloutierP Wellstead
Sep 22, 2006·American Journal of Therapeutics·Sheng Chen, Weidong Le
Sep 22, 2007·Neuroreport·Wen-Wei LiDing-Fang Cai
Aug 16, 2006·Neuro-degenerative Diseases·Oliver von Bohlen und HalbachKlaus Unsicker
Aug 16, 2006·Neuro-degenerative Diseases·O von Bohlen Und Halbach
Nov 3, 2009·Biological & Pharmaceutical Bulletin·Hong-Ning ZhangXiao-Ping Pu
Dec 18, 2013·PloS One·Yih-Ru WuChiung-Mei Chen
Sep 27, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Deok-Sang HwangMyung Sook Oh
Nov 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jennifer C LeeJay R Winkler
Jul 28, 2005·Cell and Tissue Research·N KotariaO von Bohlen Und Halbach
Nov 19, 2010·Molecular Neurobiology·Antonio SimeoneCarmine Tomasetti
Oct 3, 2014·Acta Biochimica Et Biophysica Sinica·Bingjie XieYulin Deng
Mar 31, 2005·Seminars in Cell & Developmental Biology·Sally Martin, Robert G Parton
Feb 19, 2013·Brain Research·Mohammadreza Jalali-Nadoushan, Mehrdad Roghani
Sep 19, 2008·Journal of Neuropathology and Experimental Neurology·Xuping LiWeidong Le
Jun 19, 2010·Brain Research Bulletin·Mehrdad RoghaniTourandokht Baluchnejadmojarad
Mar 17, 2010·Neuroscience Letters·Hong-Ning ZhangXiao-Ping Pu
Dec 25, 2015·Neurochemical Research·Zahra KiasalariMehrdad Roghani
Aug 12, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T N CoetseeJ J Bergh
Nov 18, 2005·Journal of Biochemical and Molecular Toxicology·Nazarius S Lamango
Jun 30, 2006·Journal of Neurochemistry·Barry Halliwell
Sep 21, 2007·The European Journal of Neuroscience·Vineeta SinghAntonello Bonci
Mar 3, 2009·Annals of the New York Academy of Sciences·Vincenzo Di MatteoGiuseppe Di Giovanni
Mar 3, 2009·Annals of the New York Academy of Sciences·Massimo PierucciGiuseppe Di Giovanni
Jan 31, 2007·Annals of the New York Academy of Sciences·Vincenzo Di MatteoGiuseppe Di Giovanni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis